Ticker Details
Black Diamond Therapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$132.75M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 3.65%
Avg Daily Range (30 D):	$0.07 | 2.71%
Avg Daily Range (90 D):	$0.09 | 2.91%

Institutional Daily Volume
Avg Daily Volume:	.74M
Avg Daily Volume (30 D):	.75M
Avg Daily Volume (90 D):	1M

Trade Size
Avg Trade Size (Sh.):	146
Avg Trade Size (Sh.) (30 D):	152
Avg Trade Size (Sh.) (90 D):	146

Institutional Trades
Total Institutional Trades:	373
Avg Institutional Trade:	$1.82M
Avg Institutional Trade (30 D):	$1.2M
Avg Institutional Trade (90 D):	$.94M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.26M
Avg Closing Trade (30 D):	$1.2M
Avg Closing Trade (90 D):	$1.2M
Avg Closing Volume:	174.82K

News

Aug 7, 2025 @ 12:23 PM Black Diamond (BDTX) Q2 Loss Narrows 47% Source: Jesterai

Aug 1, 2025 @ 4:21 PM Clarus (CLAR) Q2 Loss Beats Estimates Source: Jesterai

Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A

Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight

Nov 5, 2024 @ 1:00 PM Black Diamond Therapeutics Reports Third Quarter 2... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.15	$-.19	$1
Diluted EPS	$-.15	$-.19	$.98
Revenue	$M	$M	$70M
Gross Profit
Net Income / Loss	$-8.5M	$-10.56M	$56.54M
Operating Income / Loss	$-10.98M	$-13.42M	$54.53M
Cost of Revenue
Net Cash Flow	$.87M	$-68.43M	$61.99M
PE Ratio